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 Abstract—Pretreatment with tumor necrosis factor-
α (TNF-α) is known to trigger cardioprotection. TNF-α can 
activate multiple downstream signaling cascades. However, it is 
not known whether the mitochondrial permeability transition 
pore (MitoPTP) is involved in TNF-α-induced cardioprotection. 
In the present study, we examined whether TNF-α inhibits 
MitoPTP opening. In isolated rat hearts subjected to 30 min 
regional ischemia and 120 min reperfusion, pretreatment with 
10 U/ml TNF-α for 7 min followed by 10 min washout 
improved the recovery of left ventricular developed pressure 
(LVDP) and rate-pressure product (RPP = LVDP × heart rate) 
during reperfusion and reduced the infarct size. 
Administration of 20 µmol/L atractyloside, a MitoPTP opener, 
for 20 min (last 5 min of ischemia and first 15 min of 
reperfusion) and pretreatment with 1 µmol/L paxilline, an 
inhibitor of the Ca2+-activated K+ channel, for 5 min before 
ischemia, attenuated the recovery of LVDP and RPP and the 
reduction of infarct size induced by TNF-α. The findings 
indicate that, in the isolated heart model, TNF-α protects 
myocardium against ischemia/reperfusion injury via inhibiting 
MitoPTP opening as well as by activating the Ca2+-activated K+ 
channel. 
 
Keywords—Tumor necrosis factor-α, heart, ischemia-
reperfusion, mitochondrial permeability transition pore 
 
 
I.  INTRODUCTION 
 
 Tumor necrosis factor-α (TNF-α) is a multifunctional 
cytokine that mediates diverse physiological and 
pathophysiological events, including the ability to evoke 
protective preconditioning against ischemia and reperfusion 
injury in isolated, perfused rat and rabbit hearts [1;2]. Hearts 
from TNF-α-pretreated animals contain lower levels of 
lactate dehydrogenase than hearts from untreated rats, and 
TNF-α induces the messenger RNA for manganous 
superoxide dismutase [3]. In transgenic mice deficient in the 
TNF-α gene, ischemic preconditioning fails to decrease 
infarct size, suggesting that endogenous TNF-α is required 
for cardioprotection [4]. TNF-α activates multiple 
downstream signaling cascades related to mitochondria. 
However, the relationship between the cardioprotection 
evoked by TNF-α and mitochondria has not been elucidated. 
The mitochondrial permeability transition pore (MitoPTP) is 
a non-specific pore across the mitochondrial inner and outer 
membranes. Inhibition of MitoPTP opening is known to be 
cardioprotective [5]. Therefore, we hypothesized that 
MitoPTP may play a role in the protective effect of TNF-α 
in hearts subjected to ischemia and reperfusion. The present 
study was designed to test whether stimulation or inhibition 
of MitoPTP opening affects the cardioprotective effect of 
TNF-α. 
 
 
II.  METHODOLOGY 
 
 1) Isolated perfused heart preparation: Male Sprague-
Dawley rats (200-250g) were killed by stunning and cervical 
dislocation. Hearts were excised rapidly and placed in ice-
cold Krebs-Henseleit (K-H) buffer, then mounted on a 
constant pressure (100 cmH2O) Langendorff apparatus and 
perfused at 37°C with K-H buffer. For hearts subjected to 
regional ischemia, a 5/0 silk suture was passed under the left 
coronary artery to form a snare. The artery was occluded by 
pulling the snare to produce ischemia, while reperfusion was 
achieved by releasing it. A latex, fluid-filled balloon was 
introduced into the left ventricle through the left atrial 
appendage and the left ventricular end diastolic pressure 
(LVEDP) was adjusted to between 4 and 8 mmHg. The 
cardiac parameters heart rate (HR), left ventricular 
developed pressure (LVDP) and the rate-pressure product 
(LVDP × HR) were monitored continuously. 
 2) Infarct size measurement: For determination of 
infarct size in hearts subjected to regional ischemia, the 
coronary artery was re-occluded at the end of the 
reperfusion period and a solution of 0.5% Evans blue was 
infused to delineate the non-ischemic zone of the 
myocardium as a dark blue area. Hearts were then frozen 
and sliced into 2 mm-thick transverse sections and incubated 
in 2,3,5-triphenyl-tetrazolium chloride for 10-15 min, then 
fixed in 10% formalin to visualize the unstained (infarcted) 
region. Infarct and risk zone areas were determined by 
planimetry using Image/J software (NIH). Infarct size was 
expressed as a percentage of the risk zone. 
3) Experimental protocol: All hearts were allowed to 
equilibrate for at least 20 min and were subsequently 
subjected to a standard 30 min of regional ischemia 
followed by 120 min of reperfusion. The hearts were 
randomly assigned to one of the following 7 groups: (1) 
hearts subjected to regional ischemia and reperfusion only 
(IR); (2) hearts perfused with TNF-α (10 U/ml for 7 min) 
followed by 10 min drug-free perfusion before the standard 
ischemia; (3) 0.2 µmol/L cyclosporin A, an inhibitor of 
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MitoPTP opening, for 20 min (last 5 min of ischemia and 
first 15 min of reperfusion); (4) NS1619 (10 µmol/L), an 
activator of the Ca2+-activated K+  (KCa) channel for 10 min 
before the standard ischemia; (5) hearts treated with TNF-α 
and 20 µmol/L atractyloside, an opener of MitoPTP, for 20 
min (last 5 min of ischemia and first 15 min of reperfusion); 
(6) treatment with both NS1619 and atractyloside; and (7) 
hearts treated with TNF-α and 1 µmol/L paxilline, a blocker 
of the KCa channel, for 5 min before the standard ischemia. 
 
 
III.  RESULTS 
 
A. Effect of TNF-α, atractyloside and paxilline on 
ventricular contraction during ischemia and reperfusion 
 
 In hearts subjected to ischemia and reperfusion only, 
LVDP and LVDP×HR decreased during ischemia and 
continued to fall during the following 120 min of 
reperfusion, while LVEDP was elevated. Treatment with 10 
U/ml TNF-α or 0.2 µmol/L CsA attenuated these changes. 
Administration of atractyloside (20 µmol/L) and paxilline (1 
µmol/L) reduced the effect of TNF-α (Figs. 1, 2, 3). 
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Fig. 1.  Effect of TNF-α (10 U/ml), cyclosporin A (CsA, 0.2 
µmol/L), atractyloside (Atr, 20 µmol/L) and paxilline (Pax, 1 
µmol/L) on LVDP x HR in isolated rat heart subjected to ischemia 
and reperfusion (IR). Data expressed as mean ± SEM, n = 7-8. 
*p<0.05, **p<0.01 vs IR group; #p<0.05, ## p<0.01 vs TNF 
group. 
 
 
B.  Effect of TNF-α, atractyloside, paxilline and NS1619 on 
infarct size 
 
 The infarct size of hearts after 30 min ischemia 
followed by 120 min reperfusion was 40.72 ± 6.47% of the 
risk zone. Treatment with TNF-α, CsA and NS1619 
significantly reduced infarct size. However, atractyloside 
attenuated the reduction of infarct size induced by TNF-α 
and NS1619. Pretreatment with paxilline diminished the 
reduction of infarct size induced by TNF-α (Fig. 4). 
0
20
40
60
80
100
Baseline
IR
TNF
CsA
TNF+Atr
TNF+Pax
**
**
**
**
##
Baseline             5 min                  120 min
                         Reperfusion
C
ha
ng
e 
in
 L
VD
P 
(%
 o
f b
as
el
in
e)
 
Fig. 2.  Effect of TNF-α (10 U/ml), cyclosporin A (CsA, 0.2 
µmol/L), atractyloside (Atr, 20 µmol/L) and paxilline (Pax, 1 
µmol/L) on LVDP at 5 min and 120 min of reperfusion in isolated 
rat heart subjected to ischemia and reperfusion (IR). Data 
expressed as mean ± SEM, n = 7-8. 
**p<0.01 vs IR group; ##p<0.01 vs TNF group. 
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Fig. 3.  Effect of TNF-α (10 U/ml), cyclosporin A (CsA, 0.2 
µmol/L), atractyloside (Atr, 20  µmol/L) and paxilline (Pax, 1 
µmol/L) on LVEDP at 5 min and 120 min of reperfusion in 
isolated rat heart subjected to ischemia and reperfusion (IR). Data 
expressed as mean ± SEM, n = 7-8. 
**p<0.01 vs IR group; ## p<0.01 vs TNF group. 
 
 
IV.  DISCUSSION 
 
 In the present study, we found that pretreatment with 
TNF-α attenuated the decrease of LVDP, LVDP × HR and 
the increase of LVEDP in the isolated heart during 120 min 
reperfusion after 30 min regional ischemia, as well as 
decreasing the infarct size. This protective effect was 
attenuated by the MitoPTP opener atractyloside and the KCa 
channel blocker paxilline, indicating that cardioprotection 
induced by TNF-α is associated with inhibiting MitoPTP 
opening and activating the KCa channel. 
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Fig. 4.  Effect of TNF-α (10 U/ml), cyclosporin A (CsA, 0.2 
µmol/L), atractyloside (Atr, 20  µmol/L), paxilline (Pax, 1 µmol/L) 
and NS1619 (10 µmol/L) on infarct size in isolated rat hearts. 
Data expressed as mean ± SEM, n = 7-8. 
*p<0.05, **p<0.01 vs IR group; ##p<0.01 vs TNF group; 
++p<0.01 vs NS1619 group. 
 
 
 Our study confirmed the cardioprotective effect of TNF-
α against ischemia and reperfusion-induced myocardial 
injury reported by others [2;6]. Although some intracellular 
signal transduction pathways such as sphingolipid, NF-κB, 
AKT, and JUN are known to participate in the 
cardioprotection induced by TNF-α [6;7], the detailed 
mechanism remains to be elucidated. 
 Mitochondria are considered to lie at the “heart” of the 
cardioprotection provided by various triggers [8;9] and 
MitoPTP is the common target of the intracellular signaling 
transduction pathway [10].Therefore, since it was not clear 
how TNF-α exerted its cardioprotective effect we 
hypothesized that MitoPTP may serve as a target. In the 
present study, the MitoPTP opener atractyloside abolished 
the cardioprotective effect of TNF-α, which thus appears to 
act via MitoPTP inhibition. Furthermore, to verify the role 
of the KCa channel, we determined the effect of the KCa 
channel blocker paxilline on infarct size and ventricular 
hemodynamics in the presence of TNF-α. Pretreatment with 
paxilline attenuated the cardiac effect of TNF-α, which thus 
also appears to act via the KCa channel. It has been reported 
that KCa channel participates in the pharmacological 
protection against ischemic myocardial injury by using 
angiotensin-converting enzyme inhibitor cilazaprilat [11] 
and the KCa channel is activated and contributes to the 
regulation of coronary vascular tone during coronary  
hypoperfusion [12]. In the present study, the attenuating 
effect of NS1619, a KCa channel activator, was reduced by 
the MitoPTP opener atractyloside. This observation suggests 
that this channel, probably a mitochondrial KCa channel, is 
associated with MitoPTP and cardioprotection, and the KCa 
channel is upstream of the MitoPTP. 
 
 
V. CONCLUSION 
 
 In conclusion, this study shows that cardioprotection 
against ischemia-reperfusion induced injury by TNF-α is 
mediated by inhibiting MitoPTP opening and activating the 
KCa channel. 
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